Voyageur Pharmaceuticals Ltd. (CVE:VM – Get Free Report)’s share price traded up 50% on Thursday . The stock traded as high as C$0.11 and last traded at C$0.11. 1,942,446 shares changed hands during trading, an increase of 1,795% from the average session volume of 102,479 shares. The stock had previously closed at C$0.07.
Voyageur Pharmaceuticals Stock Performance
The company has a debt-to-equity ratio of 3.21, a quick ratio of 0.84 and a current ratio of 0.17. The stock has a market cap of C$13.95 million, a P/E ratio of -10.00 and a beta of 0.32. The business’s 50-day moving average price is C$0.07 and its 200-day moving average price is C$0.06.
About Voyageur Pharmaceuticals
Voyageur Pharmaceuticals Ltd., together with its subsidiaries, engages in the acquiring, exploring, and developing raw materials for pharmaceutical products, primarily in the province of British Columbia, Canada, and the state of Utah. The company develops barium and iodine-based APIs. The company was formerly known as Voyageur Minerals Ltd.
Featured Articles
- Five stocks we like better than Voyageur Pharmaceuticals
- Most active stocks: Dollar volume vs share volume
- Opal Fuels CEO on Steering the Future of Renewable Natural Gas
- What does consumer price index measure?
- MicroStrategy Joins Nasdaq-100: 2 Crypto Stocks Set to Win
- Diversification Can Smooth Returns And Mitigate Portfolio Risk
- 2 Underrated Quantum Computing Companies Starting to Rally
Receive News & Ratings for Voyageur Pharmaceuticals Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Voyageur Pharmaceuticals and related companies with MarketBeat.com's FREE daily email newsletter.
